Tag | Content |
---|
EnhancerAtlas ID | HS187-15929 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr21:45626260-45629080 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL2 | MA0478.1 | chr21:45627639-45627650 | GGATGACTCAG | + | 6.32 | JUNB | MA0490.1 | chr21:45627639-45627650 | GGATGACTCAG | + | 6.14 | Myod1 | MA0499.1 | chr21:45627865-45627878 | GGGGGCAGCTGCT | - | 6.03 |
|
| Number of super-enhancer constituents: 26 | ID | Coordinate | Tissue/cell |
SE_00694 | chr21:45627172-45628515 | Adipose_Nuclei | SE_03880 | chr21:45627327-45628971 | Brain_Anterior_Caudate | SE_04775 | chr21:45626030-45629668 | Brain_Cingulate_Gyrus | SE_05779 | chr21:45625585-45629669 | Brain_Hippocampus_Middle | SE_06690 | chr21:45625851-45629031 | Brain_Hippocampus_Middle_150 | SE_07737 | chr21:45627279-45628360 | Brain_Inferior_Temporal_Lobe | SE_10305 | chr21:45623380-45628791 | CD19_Primary | SE_11616 | chr21:45622912-45630050 | CD20 | SE_24239 | chr21:45625900-45626559 | Colon_Crypt_2 | SE_24239 | chr21:45626613-45628029 | Colon_Crypt_2 | SE_24239 | chr21:45628152-45628712 | Colon_Crypt_2 | SE_30176 | chr21:45627362-45628673 | Fetal_Muscle | SE_31647 | chr21:45625794-45628702 | Gastric | SE_33667 | chr21:45621645-45627097 | H2171 | SE_40890 | chr21:45625813-45629023 | Left_Ventricle | SE_42286 | chr21:45625817-45628837 | Lung | SE_48538 | chr21:45625974-45628773 | Psoas_Muscle | SE_50113 | chr21:45625833-45628971 | Sigmoid_Colon | SE_51445 | chr21:45624818-45629069 | Skeletal_Muscle | SE_52463 | chr21:45625843-45628782 | Small_Intestine | SE_56643 | chr21:45626252-45630945 | u87 | SE_59125 | chr21:45557380-45640832 | Ly3 | SE_61237 | chr21:45557180-45641526 | HBL1 | SE_61527 | chr21:45545883-45641600 | Toledo | SE_62281 | chr21:45556124-45641130 | Tonsil | SE_65639 | chr21:45625460-45628847 | Pancreatic_islets |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH21I044205 | chr21 | 45625272 | 45628706 | GH21I005055 | chr21 | 45625955 | 45628553 |
|
Enhancer Sequence | TTTCTAGGCC CCGCCTGTGG TCCTCTGTTG CAGCAGCCTG GACAGTCTGG ACTGCCTGGA 60 CAGCATGCAG ATGGGCTCTG CCCGCGGCTG CCCACGAGTT CCCACCGCCC GCCCGTCCGT 120 GGGAGAGCCA GTCCTCGTAT GTGAAGCGTA CCTGTATCCC TTTACTCCGC GTACACAGGT 180 GCCTTTGTCA CTTCTCCTTT GACCTGGCTG GCACATCTTA CCGGTTTCTG CGCTAACAAT 240 GAGTTGAAGG AAATCTTGAA CGCGCGTTCA TTTTATATCG GTATCAGAGT CTGTTTATTT 300 CTTGTTGACA CTAATCTTTG AGCATGAGTA GTTTAGTGAT TGTGAAACAG AAACTTCTGG 360 ATACAAAATC AGTCTCCTGG CTGTGACCCA ATCATCTTCG CAGTTCTGAT TACCTGTGAT 420 TAAGAAAATA AATAAGAACA CCCATTGGGG GAAGGCTTCC CTCCCCCGGG CACAGCAGCT 480 TTAAAACCGA AAGGGAAGTG GGTGCTGTGA GCAGCTCTGT TCAGGCCTAA GGCCACGCAT 540 GTGTGCCCCG TGGGGGAGAC ATGCACCAGC GAATCAGGAA ACAGTGGTGA CAGCCGTTCC 600 GGGAGGCTGA CTGGGGGTGC AGGGGTCACT TTTCTAATGT GGGTGGGTCT GTGTCCCCTG 660 CAGGAACGTG GCTGCAGCAA AGCCGGTCAG CCAGCGGTCA GCTCCAGCCC CTGTCCAGGC 720 CCTGTGGGTC CTGCTGACCA GGCTGCGGTT GTTCCCAAAC CAGTTCCCAG CCCCCGCTTG 780 CCCTACTTCC TCTCACACCA GCTCCTTCCA CCCCCTCACA CCCACCTGCA GGCTCCCAGC 840 CCAGGCTACT GACATCAATC ATGGCAATCG CTATTCCAGA GGTATACGCG GTGGGTGGGG 900 TCCGGTATCG CCTGCCATGC CTCACTCACC GGGCACCCAG ATAACCTGAG GCCAGGGAGC 960 AGCCACTCGC CCTGACCCAT GCTCCCCGGG CCCCTGAGGC ACCCAGGAGG ACCACCCGGC 1020 CGCTTCTGCT CAGAGCCCAG CACCCCCGAG TCTGTGAAGA GGTCACATCT GACCACGTTT 1080 CCAGGTGGCT GCCCAGGCGT GGGTTCATGG CCGCTTCCGG TTTCCTCCTC GAGCTGAACC 1140 ACACACCTGC TCTGTCCCGG GCTTTCTGGA GGGGTTTTCC GAAGTGAGAC TGTGGGCTCC 1200 CTCCAGGGCT GGGGGCAGGA GGACACACGG GGAAGGTGGG CAAGCAGCCC CAGGCTGAGG 1260 GAGGCCTCCC CTCTGCAGCG TTTGTTCATT CATTTGTTCA TCGCTAACAC TGTCTTGGGC 1320 ATCAGGGAAA ACAGGTGTCT CTGGTCCACA TGCAGAAGAG CCACCACCGT GGCACGACTG 1380 GATGACTCAG ACCCCGGGCG GGGGGTATGA TTTGGACACA GTCATTGTCC AGGGACACAA 1440 CTTTGCCTGG ACCAGAGCTT CTCACCCCCA GGCCATTTGA AACCCCAGGG GATACTCGAC 1500 AAAGTCCAGA GACATTTTGG GTTGTTCCTT TCCAGCCCCG GCGATGGTGG GGACGTGTCC 1560 ATGTCTGTGT CCCTCCGGTC ACTCTCTCTG GCCCTCTCCC TCCCTGGGGG CAGCTGCTCT 1620 CAGCCCTCCC TGCCCCCACA TCGCCATCCT GCCTGTCCTT CTGGGCCTGC ACGTTTGTTG 1680 TGTTTGGAAG GAGCCACCAA GGAGGAGGAT GTCAATGTGC AAGTTCTCAG GGAAGCAGGC 1740 CCCGCAGCCT CCGTCAGTGT CTTCCGTCCG CAGGAAGAAC CCAGGCCTGG GTGATTCATC 1800 GGGGCCTCAG GGCCGGGAGG CACTAAATCT TCTGCAGATG TGGTAAGATC CTATCACAGC 1860 AGAAAGGGAA GGGCTAGAGT CTCAGGGAAG GTTTTGCTAG GGAGACGGGC TTGGAGGGGG 1920 CTGAGGCTCA TGGGAGCTGC AAGGGTACAG GAGGGGAGGG GACCCCAGGG CAGGTGGATG 1980 GACACCTGGG TGGGTAAGAA AAGGGCCTCT CAGAGGGCAA GGGAGGGCCA GGGAGGGAGC 2040 AGTGAGCCCT GACTGACTGT ACAAGCTTAA CTGGCTGCCC TTGTCCTGCA GGTGGTGTGG 2100 GCTGTGTGGA TTTCGGATGT GGGCCCATAA CATAGCCACA CTGCTGCAAA GCAAGTGAGT 2160 CTGAGGCAAG AAGAAGGCCC AACCTTGGGA GGCTGACCTG GAGGGCAGGC AGAGGCAGGT 2220 GGTAAGGACC TGCCTTACCT GTTGAGGTGA CAGTGGGGGA CATATTGCAA GGAAGGAGGC 2280 CCTGGATCCT CAGGATGTGG ATGGTGGGTA GAAGGGTGAC AGCTAATGGA TGTCCACCTG 2340 CACAGATGCC CACCTGCATG AGTGCCCACC TGCATGAGTG CCCACTTGTA CCAATGTCCA 2400 CCTGTACAGA TGTCCACATG CAAATGCCCA TCTGCACTGA TATCCACCTG CACAGATGCC 2460 TACCTGCATG AATACCCACT TGCCTGAAAG CCCACCTGCA CCCATGTCCA CTGGCACAAA 2520 TGCCCACCTG CACCCGTGTC CACTGGCACA AATGCCCACC TGCACAGAAG CCCACCCACA 2580 CAAATGCCCA CCTGCAAAAA TGTCCGCCTG CACAGATGTC CACCTGCATG AATGCCCACC 2640 TGTGTCCACA TGCACGAATA CCCACCTGCA CAGATGCCCA CCTGCACGGA TGCCCACCTG 2700 TACAAAGGCC TACCTGCGTG AATGTCCACC TGCATGGATG CCCACCCGCA CGGATGCCCA 2760 CCTGCACAGT TATCCATCTG AACAGCCCTC TGGTGCCTCC TTTTGCTTGC ACATGTTCAA 2820
|